Company intelligence / Profile preview

Harvard Apparatus Regenerative Technology

Holliston, Massachusetts, United Stateshregen.com ↗

Ownership: Private
Development stage: Phase 1

Overview

The company initiated a Phase 1 clinical trial in 10 patients to assess safety and clinical efficacy of their Cellspan Esophageal Implant. The first two sites, Mayo Clinic and University of Michigan, were activated in July and August 2023 to recruit patients. The company previously conducted the world's first successful regeneration of the esophagus in a patient with esophageal cancer in August 2017, performed by Dr. Dennis Wigle at Mayo Clinic, with results published in August 2021[1][6][7].

Therapeutic areas: GastroenterologyOncologyRare Diseases
Modalities: Stem cell therapyTissue engineering
Industry: Biotech

Drug pipeline

3 assets

Cellspan Bronchial Implant

Preclinical

2 more assets in the full pipeline.

Request access →

Partnerships

Capital Institute of Pediatrics (China)Mayo ClinicUniversity of Michigan

Beyond the preview

Go deeper on Harvard Apparatus Regenerative Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harvard Apparatus Regenerative Technology.

Explore the full profile